Toth I - Search Results

1

Self-adjuvanting polymer-peptide conjugates as therapeutic vaccine candidates against cervical cancer.

Liu TY, Hussein WM, Jia Z, Ziora ZM, McMillan NA, Monteiro MJ, Toth I, Skwarczynski M. Liu TY, et al. Among authors: toth i. Biomacromolecules. 2013 Aug 12;14(8):2798-806. doi: 10.1021/bm400626w. Epub 2013 Jul 22. Biomacromolecules. 2013. PMID: 23837675

2

Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens.

Olive C, Batzloff M, Horváth A, Clair T, Yarwood P, Toth I, Good MF. Olive C, et al. Among authors: toth i. Infect Immun. 2003 May;71(5):2373-83. doi: 10.1128/IAI.71.5.2373-2383.2003. Infect Immun. 2003. PMID: 12704107 Free PMC article.

3

Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct.

Olive C, Batzloff M, Horváth A, Clair T, Yarwood P, Toth I, Good MF. Olive C, et al. Among authors: toth i. Indian J Med Res. 2004 May;119 Suppl:88-94. Indian J Med Res. 2004. PMID: 15232170

4

Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.

Olive C, Sun HK, Ho MF, Dyer J, Horváth A, Toth I, Good MF. Olive C, et al. Among authors: toth i. J Infect Dis. 2006 Aug 1;194(3):316-24. doi: 10.1086/505580. Epub 2006 Jun 30. J Infect Dis. 2006. PMID: 16826479

5

Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluation.

Moyle PM, Olive C, Ho MF, Good MF, Toth I. Moyle PM, et al. Among authors: toth i. J Med Chem. 2006 Oct 19;49(21):6364-70. doi: 10.1021/jm060475m. J Med Chem. 2006. PMID: 17034142

6

Toward the development of prophylactic and therapeutic human papillomavirus type-16 lipopeptide vaccines.

Moyle PM, Olive C, Ho MF, Pandey M, Dyer J, Suhrbier A, Fujita Y, Toth I. Moyle PM, et al. Among authors: toth i. J Med Chem. 2007 Sep 20;50(19):4721-7. doi: 10.1021/jm070287b. Epub 2007 Aug 17. J Med Chem. 2007. PMID: 17705361

7

Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates.

Abdel-Aal AB, Batzloff MR, Fujita Y, Barozzi N, Faria A, Simerska P, Moyle PM, Good MF, Toth I. Abdel-Aal AB, et al. Among authors: toth i. J Med Chem. 2008 Jan 10;51(1):167-72. doi: 10.1021/jm701091d. Epub 2007 Dec 12. J Med Chem. 2008. PMID: 18072728

8

Towards the development of a broadly protective group a streptococcal vaccine based on the Lipid-Core Peptide system.

Olive C, Moyle PM, Toth I. Olive C, et al. Among authors: toth i. Curr Med Chem. 2007;14(28):2976-88. doi: 10.2174/092986707782794069. Curr Med Chem. 2007. PMID: 18220734 Review.

9

Self-adjuvanting lipopeptide vaccines.

Moyle PM, Toth I. Moyle PM, et al. Among authors: toth i. Curr Med Chem. 2008;15(5):506-16. doi: 10.2174/092986708783503249. Curr Med Chem. 2008. PMID: 18289006 Review.

10

Synthesis and immunological evaluation of self-adjuvanting glycolipopeptide vaccine candidates.

Fujita Y, Abdel-Aal AB, Wimmer N, Batzloff MR, Good MF, Toth I. Fujita Y, et al. Among authors: toth i. Bioorg Med Chem. 2008 Oct 1;16(19):8907-13. doi: 10.1016/j.bmc.2008.08.064. Epub 2008 Aug 29. Bioorg Med Chem. 2008. PMID: 18789866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,004 results

Search Page

Filters